Deletion of the Fc receptors γ chain preserves endothelial function affected by hypercholesterolaemia in mice fed on a high-fat diet

Cardiovascular Research

Volumn 80, Issue 3, 2008, Pages 463-470

  Sumiyoshi, Katsuhiko ^a   Mokuno, Hiroshi ^a   Iesaki, Takafumi ^a   Shimada, Kazunori ^a   Miyazaki, Tetsuro ^a   Kume, Atsumi ^a   Kiyanagi, Takashi ^a   Kuremoto, Kenichi ^a   Watanabe, Yoshiro ^a   Tada, Nobuhiro ^b   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial function; Fc receptors; Hypercholesterolaemia; Oxidative stress; p22phox

Indexed keywords

ACETYLCHOLINE; FC RECEPTOR; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUORESCENCE; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LIPID DIET; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; DIETARY FATS; ENDOTHELIUM, VASCULAR; GENE DELETION; HYPERCHOLESTEROLEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITROPRUSSIDE; OXIDATIVE STRESS; RECEPTORS, IGG; SUPEROXIDES; VASODILATION; VASODILATOR AGENTS;

EID: 56549092746     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn206     Document Type: Article

References (40)

1. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994;330:1036-1040.
2. McSorley PT, Bell PM, Young IS, Atkinson AB, Sheridan B, Fee JP et al. Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial. Diabet Med 2005;22:703-710.
3. Noma K, Goto C, Nishioka K, Hara K, Kimura M, Umemura T et al. Smoking, endothelial function, and Rho-kinase in humans. Arterioscler Thromb Vasc Biol 2005;25:2630-2635.
4. Thorne S, Mullen MJ, Clarkson P, Donald AE, Deanfield JE. Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. J Am Coll Cardiol 1998;32:110-116.
5. Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y. Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients. Int J Cardiol 2004;94:111-117.
6. -/- mice involves NO but not prostacyclin-dependent mechanisms. Cardiovasc Res 2002;53:253-262.
7. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation 2004;109:II27-II33.
8. Iesaki T, Gupte SA, Kaminski PM, Wolin MS. Inhibition of guanylate cyclase stimulation by NO and bovine arterial relaxation to peroxynitrite and H2O2. Am J Physiol 1999;277:H978-H985.
9. Takeya R, Sumimoto H. Molecular mechanism for activation of superoxide-producing NADPH oxidases. Mol Cells 2003;16:271-277.
10. Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 2003;10:63-71.
11. Komine-Kobayashi M, Chou N, Mochizuki H, Nakao A, Mizuno Y, Urabe T. Dual role of Fcgamma receptor in transient focal cerebral ischemia in mice. Stroke 2004;35:958-963.
12. Huang Y, Fleming AJ, Wu S, Virella G, Lopes-Virella MF. Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase. Arterioscler Thromb Vasc Biol 2000;20:2533-2538.
13. Kanamaru Y, Nakao A, Shirato I, Okumura K, Ogawa H, Tomino Y et al. Chronic graft-versus-host autoimmune disease in Fc receptor gamma chain-deficient mice results in lipoprotein glomerulopathy. J Am Soc Nephrol 2002;13:1527-1533.
14. Jancar S, Sanchez Crespo M. Immune complex-mediated tissue injury: a multistep paradigm. Trends Immunol 2005;26:48-55.
15. Ravetch JV. IgG Fc Receptors. Annu Rev Immunol 2001;19:275-290.
16. Devaraj S, Davis B, Simon SI, Jialal I. CRP promotes monocyte-endothelial cell adhesion via Fcγ receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol 2006; 291:H1170-H1176.
17. Yoshimaru T, Suzuki Y, Matsui T, Yamashita K, Ochiai T, Yamaki M et al. Blockade of superoxide generation prevents high-affinity immunoglobulin E receptor-mediated release of allergic mediators by ratmast cell line and human basophils. Clin Exp Allergy 2002;32:612-618.
18. Suzuki Y, Yoshimaru T, Matsui T, Inoue T, Niide O, Nunomura S et al. Fc epsilon RI signaling of mast cells activates intracellular production of hydrogen peroxide: role in the regulation of calcium signals. J Immunol 2003;171:6119-6127.
19. Suzuki Y, Yoshimaru T, Inoue T, Niide O, Ra C. Role of oxidants in mast cell activation. Chem Immunol Allergy 2005;87:32-42.
20. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994;76:519-529.
21. Szalai AJ, Barnum SR. Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis. J Neurosci Res 2004;75: 597-602.
22. Yagyu H, Ishibashi S, Chen Z, Osuga J, Okazaki M, Perrey S et al. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice. J Lipid Res 1999;40:1677-1685.
23. Mehrabian M, Qiao JH, Hyman R, Ruddle D, Laughton C, Lusis AJ. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. Arterioscler Thromb 1993;13:1-10.
24. Denise C, Fernandes JW Jr, Pescatore LA, Bertoline MA, Liberman M, Laurindo FRM et al. Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems. Am J Physiol Cell Physiol 2007;292: C413-C422.
25. Takaya T, Hirata K, Yamashita T, Shinohara M, Sasaki N, Inoue N et al. A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression. Arterioscler Thromb Vasc Biol 2007;27:1632-1637.
26. Li Z, Iwai M, Wu L, Liu HW, Chen R, Jinno Tet al. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis. Hypertension 2004;44:758-763.
27. Keston AS, Brandt R. The fluorometric analysis of ultramicro quantities of hydrogen peroxide. Anal Biochem 1965;11:1-5.
28. Amer J, Goldfarb A, Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 2003;70:84-90.
29. Hadi HAR, Carr CS, Suwaidi JAL. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 2005;1: 183-198.
30. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent cronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519-2524.
31. Matsui T, Suzuki Y, Yamashita K, Yoshimaru T, Suzuki-Karasaki M, Hayakawa S et al. Diphenyleneiodonium prevents reactive oxygen species generation, tyrosine phosphorylation, and histamine release in RBL-2H3 mast cells. Biochem Biophys Res Commun 2000;276:742-748.
32. Lopes-Virella MF. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Eur Heart J 1993;14(Suppl. K):118-124.
33. Fu T, Borensztajn J. Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions. Biochem J 2002;366:195-201.
34. Ratcliffe NR, Kennedy SM, Morganelli PM. Immunocytochemical detection of Fcgamma receptors in human atherosclerotic lesions. Immunol Lett 2001;77:169-174.
35. Calverley DC, Varteresian T, Brass E, Tsao-Wei DD, Groshen S, Mack WJ et al. Association between monocyte Fcgamma subclass expression and acute coronary syndrome. Immun Ageing 2004;1:4.
36. Leppers-van de Straat FGJ, van der Pol WL, Jansen MD, Sugita N, Yoshie H, Kobayashi Tet al. A novel PCR-based method for direct Fc gamma receptor IIIa (CD16) allotyping. J Immunol Methods 2000;242:127-132.
37. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K et al. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997;100:1059- 1070.
38. Hernández-Vargas P, Ortiz-Muñoz G, López-Franco O, Suzuki Y, Gallego-Delgado J, Sanjuán G et al. Fc receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. Circ Res 2006;99:1188-1196.
39. Yuan Z, Kishimoto C, Sano H, Shioji K, Xu Y, Yokode M. Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion. Am J Physiol Heart Circ Physiol 2003;285:H899-H906.
40. Konishi H, Katoh Y, Takaya N, Kashiwakura Y, Itoh S, Ra C et al. Platelets activated by collagen through immunoreceptor tyrosine-based activation motif play pivotal role in initiation and generation of neointimal hyperplasia after vascular injury. Circulation 2002;105:912-916.